Cargando…
Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation
STUDY OBJECTIVES: To present results from in vivo studies underlying the preclinical development of lemborexant (E2006), a novel dual orexin (hypocretin) receptor antagonist for sleep/wake regulation. METHODS: Rodent (wild-type rats and wild-type and orexin neuron-deficient [orexin/ataxin-3 Tg/+] mi...
Autores principales: | Beuckmann, Carsten Theodor, Ueno, Takashi, Nakagawa, Makoto, Suzuki, Michiyuki, Akasofu, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559177/ https://www.ncbi.nlm.nih.gov/pubmed/30923834 http://dx.doi.org/10.1093/sleep/zsz076 |
Ejemplares similares
-
On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers
por: Vermeeren, Annemiek, et al.
Publicado: (2018) -
Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
por: Kärppä, Mikko, et al.
Publicado: (2020) -
The effect of sleep–wake intraindividual variability in digital cognitive behavioral therapy for insomnia: a mediation analysis of a large-scale RCT
por: Vestergaard, Cecilie L, et al.
Publicado: (2021) -
Externalizing Behaviors and Callous-Unemotional Traits: Different Associations With Sleep Quality
por: Denis, Dan, et al.
Publicado: (2017) -
The association of insomnia and sleep apnea with deployment and combat exposure in the entire population of US army soldiers from 1997 to 2011: a retrospective cohort investigation
por: Caldwell, John A, et al.
Publicado: (2019)